Simulation in In Vitro Bioequivalence for Particle Sizes
![](https://nanopharm.co.uk/wp-content/uploads/2023/09/AptarPharmaScientificPublications_Icon.jpg)
Explore Simulation-informed design in in-vitro bioequivalence trials for particle size distributions’ performance.
In Vitro System for Orally Inhaled Drug Release
![](https://nanopharm.co.uk/wp-content/uploads/2023/09/AptarPharmaScientificPublications_Icon.jpg)
Discover the development of an in vitro dissolution and release system from Nanopharm for OINDPs (orally inhaled drug products).
Raman Spectroscopy for Nasal Suspension Drugs
![](https://nanopharm.co.uk/wp-content/uploads/2023/09/AptarPharmaScientificPublications_Icon.jpg)
Explore a systematic approach in developing Morphologically-Directed Raman Spectroscopy for characterizing nasal suspension drug products.
Faster, Cost-Effective Alternative to Generic Bioequivalence
![](https://nanopharm.co.uk/wp-content/uploads/2023/09/AptarPharmaScientificPublications_Icon.jpg)
Discover SmartTrack to advance the development of OINDPs. Streamline inhalation and nasal therapies with optimized particle size distribution.
Challenges in OINDPs Achieving Q3 Equivalence
![](https://nanopharm.co.uk/wp-content/uploads/2023/09/AptarPharmaScientificPublications_Icon.jpg)
Nanopharm review the bioequivalence challenges for OINDPs by achieving Q3 structural equivalence.
Trade Marks Registration Certificate for Nanopharm Ltd
![](https://nanopharm.co.uk/wp-content/uploads/2023/07/Nanopharmlogo.png)
Discover Nanopharm’s leading role in pharmaceutical research, specializing in OINDP, nasal, and inhaled pharmaceutical solutions.
Cohesive-Adhesive Balances in DPIs
![](https://nanopharm.co.uk/wp-content/uploads/2023/09/AptarPharmaScientificPublications_Icon.jpg)
Explore Dry Powder Inhaler development through Atomic Force Microscopy. Uncover Cohesive-Adhesive balances in OINDP for effective inhaler formulations.